Thiazole Derivatives in Diabetes Management: Recent Progress and Future Perspective

Objectives: This review explores the potential of thiazole derivatives as innovative anti-diabetic agents, emphasizing their structural diversity and effectiveness in Type-II diabetes mellitus. Theoretical Framework: Diabetes mellitus (DM), characterized by chronic hyperglycemia, is a progressive metabolic disorder affecting millions worldwide. Heterocyclic compounds, mainly thiazole derivatives, have recently shown promise as novel anti-diabetic agents with the potential to target specific mechanisms in DM2. Method: This review focuses on findings from recent studies on thiazole derivatives for diabetes management, focusing on synthetic routes, structural diversity, and therapeutic activities. The structure-activity relationship (SAR) along with the synthesis procedure of thiazole derivatives is also discussed to understand their pharmacological potential. Results and Discussion: Thiazole derivatives demonstrated significant activity in both in vitro and in vivo models, confirming their affinity for diabetic targets, which supports their potential as diabetic treatments. The review highlights the need for further research in SAR analysis and toxicological evaluations to optimize the therapeutic profile of these compounds. Research Implications: This review underscores the need for advanced research into the safety and selectivity of thiazole derivatives, suggesting that future studies should focus on toxicological assessments and SAR studies. Effective translation of these compounds into clinical applications may provide a new avenue for DM2 treatment and improve the current anti-diabetic drug landscape. Originality: This review highlighting key research gap and it offers a pathway for future investigations in developing safe and selective thiazole derivatives-based treatments for diabetes.